Frank Straube

Summary

Affiliation: Novartis Institutes for BioMedical Research

Publications

  1. ncbi Contact allergens and irritants show discrete differences in the activation of human monocyte-derived dendritic cells: consequences for in vitro detection of contact allergens
    Frank Straube
    Novartis Pharma AG, 4002, Basel, Switzerland
    Arch Toxicol 79:37-46. 2005
  2. ncbi Sotrastaurin and tacrolimus coadministration: effects on pharmacokinetics and biomarker responses
    John M Kovarik
    Novartis Pharma, Building WSJ 210 427, 4002 Basel, Switzerland
    J Clin Pharmacol 50:1260-6. 2010
  3. ncbi Sotrastaurin and cyclosporine drug interaction study in healthy subjects
    John M Kovarik
    Novartis Pharmaceuticals, Basel, Switzerland
    Biopharm Drug Dispos 31:331-9. 2010

Collaborators

Detail Information

Publications3

  1. ncbi Contact allergens and irritants show discrete differences in the activation of human monocyte-derived dendritic cells: consequences for in vitro detection of contact allergens
    Frank Straube
    Novartis Pharma AG, 4002, Basel, Switzerland
    Arch Toxicol 79:37-46. 2005
    ..In the concentration range around the lowest cytotoxic concentration, the assay may be able to discriminate between contact allergens and irritants...
  2. ncbi Sotrastaurin and tacrolimus coadministration: effects on pharmacokinetics and biomarker responses
    John M Kovarik
    Novartis Pharma, Building WSJ 210 427, 4002 Basel, Switzerland
    J Clin Pharmacol 50:1260-6. 2010
    ....
  3. ncbi Sotrastaurin and cyclosporine drug interaction study in healthy subjects
    John M Kovarik
    Novartis Pharmaceuticals, Basel, Switzerland
    Biopharm Drug Dispos 31:331-9. 2010
    ..The authors determined the effect of combining sotrastaurin with the calcineurin inhibitor cyclosporine on the pharmacokinetics and biomarker responses to both drugs...